nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—Disease progression—Carmustine—malignant glioma	0.0849	0.141	CcSEcCtD
Leucovorin—Febrile neutropenia—Carmustine—malignant glioma	0.0308	0.0513	CcSEcCtD
Leucovorin—Febrile neutropenia—Temozolomide—malignant glioma	0.0298	0.0496	CcSEcCtD
Leucovorin—Rigors—Temozolomide—malignant glioma	0.0219	0.0366	CcSEcCtD
Leucovorin—Extravasation—Carmustine—malignant glioma	0.0212	0.0354	CcSEcCtD
Leucovorin—Neuropathy—Carmustine—malignant glioma	0.0174	0.029	CcSEcCtD
Leucovorin—Neuropathy—Temozolomide—malignant glioma	0.0168	0.028	CcSEcCtD
Leucovorin—TYMS—One Carbon Metabolism—DNMT3B—malignant glioma	0.0152	0.0381	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—CTNND2—malignant glioma	0.0145	0.0362	CbGpPWpGaD
Leucovorin—TYMS—Trans-sulfuration and one carbon metabolism—DNMT3B—malignant glioma	0.0137	0.0342	CbGpPWpGaD
Leucovorin—ABCC3—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.0131	0.0326	CbGpPWpGaD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.0124	0.0311	CbGpPWpGaD
Leucovorin—ABCC2—Irinotecan Pathway—BCHE—malignant glioma	0.0123	0.0306	CbGpPWpGaD
Leucovorin—ABCC2—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.0104	0.0259	CbGpPWpGaD
Leucovorin—Neuropathy peripheral—Carmustine—malignant glioma	0.0102	0.0169	CcSEcCtD
Leucovorin—Stomatitis—Carmustine—malignant glioma	0.0101	0.0168	CcSEcCtD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00986	0.0247	CbGpPWpGaD
Leucovorin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00982	0.0164	CcSEcCtD
Leucovorin—Stomatitis—Temozolomide—malignant glioma	0.00977	0.0163	CcSEcCtD
Leucovorin—Alopecia—Carmustine—malignant glioma	0.00822	0.0137	CcSEcCtD
Leucovorin—Erythema—Carmustine—malignant glioma	0.0081	0.0135	CcSEcCtD
Leucovorin—Chills—Temozolomide—malignant glioma	0.00807	0.0135	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—STMN1—malignant glioma	0.00795	0.0199	CbGpPWpGaD
Leucovorin—Alopecia—Temozolomide—malignant glioma	0.00795	0.0132	CcSEcCtD
Leucovorin—Erythema—Temozolomide—malignant glioma	0.00783	0.0131	CcSEcCtD
Leucovorin—Dysgeusia—Temozolomide—malignant glioma	0.00767	0.0128	CcSEcCtD
Leucovorin—Ill-defined disorder—Temozolomide—malignant glioma	0.00726	0.0121	CcSEcCtD
Leucovorin—Leukopenia—Carmustine—malignant glioma	0.00725	0.0121	CcSEcCtD
Leucovorin—Malaise—Temozolomide—malignant glioma	0.00706	0.0118	CcSEcCtD
Leucovorin—Convulsion—Carmustine—malignant glioma	0.00702	0.0117	CcSEcCtD
Leucovorin—Leukopenia—Temozolomide—malignant glioma	0.00701	0.0117	CcSEcCtD
Leucovorin—Convulsion—Temozolomide—malignant glioma	0.00678	0.0113	CcSEcCtD
Leucovorin—Confusional state—Carmustine—malignant glioma	0.00667	0.0111	CcSEcCtD
Leucovorin—ABCC2—Irinotecan Pathway—APC—malignant glioma	0.00665	0.0166	CbGpPWpGaD
Leucovorin—Discomfort—Temozolomide—malignant glioma	0.00659	0.011	CcSEcCtD
Leucovorin—Infection—Carmustine—malignant glioma	0.00657	0.0109	CcSEcCtD
Leucovorin—Thrombocytopenia—Carmustine—malignant glioma	0.00647	0.0108	CcSEcCtD
Leucovorin—Confusional state—Temozolomide—malignant glioma	0.00644	0.0107	CcSEcCtD
Leucovorin—Anaphylactic shock—Temozolomide—malignant glioma	0.00639	0.0107	CcSEcCtD
Leucovorin—Infection—Temozolomide—malignant glioma	0.00635	0.0106	CcSEcCtD
Leucovorin—Anorexia—Carmustine—malignant glioma	0.0063	0.0105	CcSEcCtD
Leucovorin—Thrombocytopenia—Temozolomide—malignant glioma	0.00626	0.0104	CcSEcCtD
Leucovorin—Skin disorder—Temozolomide—malignant glioma	0.00621	0.0103	CcSEcCtD
Leucovorin—Anorexia—Temozolomide—malignant glioma	0.00609	0.0102	CcSEcCtD
Leucovorin—Dyspnoea—Carmustine—malignant glioma	0.0059	0.00983	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—FTH1—malignant glioma	0.00585	0.0146	CbGpPWpGaD
Leucovorin—Decreased appetite—Carmustine—malignant glioma	0.00575	0.00958	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00571	0.00952	CcSEcCtD
Leucovorin—Dyspnoea—Temozolomide—malignant glioma	0.0057	0.0095	CcSEcCtD
Leucovorin—Constipation—Carmustine—malignant glioma	0.00565	0.00942	CcSEcCtD
Leucovorin—Dyspepsia—Temozolomide—malignant glioma	0.00562	0.00938	CcSEcCtD
Leucovorin—Decreased appetite—Temozolomide—malignant glioma	0.00555	0.00926	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00552	0.0092	CcSEcCtD
Leucovorin—Fatigue—Temozolomide—malignant glioma	0.00551	0.00918	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—FTH1—malignant glioma	0.0055	0.0138	CbGpPWpGaD
Leucovorin—Constipation—Temozolomide—malignant glioma	0.00546	0.00911	CcSEcCtD
Leucovorin—Feeling abnormal—Carmustine—malignant glioma	0.00545	0.00908	CcSEcCtD
Leucovorin—Gastrointestinal pain—Carmustine—malignant glioma	0.00541	0.00901	CcSEcCtD
Leucovorin—Feeling abnormal—Temozolomide—malignant glioma	0.00527	0.00878	CcSEcCtD
Leucovorin—Abdominal pain—Carmustine—malignant glioma	0.00523	0.00871	CcSEcCtD
Leucovorin—Body temperature increased—Carmustine—malignant glioma	0.00523	0.00871	CcSEcCtD
Leucovorin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00523	0.00871	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—NTRK3—malignant glioma	0.00509	0.0127	CbGpPWpGaD
Leucovorin—Urticaria—Temozolomide—malignant glioma	0.00508	0.00846	CcSEcCtD
Leucovorin—Body temperature increased—Temozolomide—malignant glioma	0.00505	0.00842	CcSEcCtD
Leucovorin—Abdominal pain—Temozolomide—malignant glioma	0.00505	0.00842	CcSEcCtD
Leucovorin—Hypersensitivity—Carmustine—malignant glioma	0.00487	0.00812	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—PIM1—malignant glioma	0.00477	0.0119	CbGpPWpGaD
Leucovorin—Asthenia—Carmustine—malignant glioma	0.00474	0.00791	CcSEcCtD
Leucovorin—Hypersensitivity—Temozolomide—malignant glioma	0.00471	0.00785	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TOP2A—malignant glioma	0.00466	0.0116	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—FTH1—malignant glioma	0.00464	0.0116	CbGpPWpGaD
Leucovorin—Asthenia—Temozolomide—malignant glioma	0.00458	0.00764	CcSEcCtD
Leucovorin—Diarrhoea—Carmustine—malignant glioma	0.00452	0.00754	CcSEcCtD
Leucovorin—Pruritus—Temozolomide—malignant glioma	0.00452	0.00754	CcSEcCtD
Leucovorin—Dizziness—Carmustine—malignant glioma	0.00437	0.00729	CcSEcCtD
Leucovorin—Diarrhoea—Temozolomide—malignant glioma	0.00437	0.00729	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00424	0.0106	CbGpPWpGaD
Leucovorin—Dizziness—Temozolomide—malignant glioma	0.00423	0.00704	CcSEcCtD
Leucovorin—Vomiting—Carmustine—malignant glioma	0.0042	0.00701	CcSEcCtD
Leucovorin—Rash—Carmustine—malignant glioma	0.00417	0.00695	CcSEcCtD
Leucovorin—Dermatitis—Carmustine—malignant glioma	0.00417	0.00694	CcSEcCtD
Leucovorin—Vomiting—Temozolomide—malignant glioma	0.00406	0.00677	CcSEcCtD
Leucovorin—Rash—Temozolomide—malignant glioma	0.00403	0.00672	CcSEcCtD
Leucovorin—Dermatitis—Temozolomide—malignant glioma	0.00403	0.00671	CcSEcCtD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00398	0.00996	CbGpPWpGaD
Leucovorin—Nausea—Carmustine—malignant glioma	0.00393	0.00655	CcSEcCtD
Leucovorin—Nausea—Temozolomide—malignant glioma	0.0038	0.00633	CcSEcCtD
Leucovorin—TYMS—Nucleotide metabolism—CAT—malignant glioma	0.00366	0.00915	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—TUBG2—malignant glioma	0.00339	0.00847	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—TOP2A—malignant glioma	0.00328	0.00819	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00321	0.00803	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—KNG1—malignant glioma	0.00316	0.00791	CbGpPWpGaD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00316	0.00789	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—SOX2—malignant glioma	0.00307	0.00768	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00305	0.00761	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TUBG2—malignant glioma	0.00303	0.00757	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—KNG1—malignant glioma	0.00301	0.00753	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—SOD1—malignant glioma	0.00294	0.00734	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—DOCK6—malignant glioma	0.00294	0.00734	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—malignant glioma	0.0028	0.007	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00271	0.00679	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PML—malignant glioma	0.00261	0.00651	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00248	0.00621	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TOP2A—malignant glioma	0.00238	0.00596	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN2B—malignant glioma	0.00235	0.00587	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—SLC5A5—malignant glioma	0.00234	0.00585	CbGpPWpGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—TP53—malignant glioma	0.00231	0.00577	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—PDGFB—malignant glioma	0.00227	0.00567	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—SLC6A3—malignant glioma	0.00223	0.00557	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—SLC5A5—malignant glioma	0.0022	0.0055	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—CDKN2A—malignant glioma	0.0022	0.00549	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—PDGFB—malignant glioma	0.00216	0.0054	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—SLC6A3—malignant glioma	0.00209	0.00523	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00205	0.00512	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—FN1—malignant glioma	0.00204	0.00511	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—RTEL1—malignant glioma	0.00202	0.00505	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—malignant glioma	0.00195	0.00487	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—EGF—malignant glioma	0.00193	0.00483	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00193	0.00483	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00193	0.00482	CbGpPWpGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TP53—malignant glioma	0.00191	0.00477	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—GSTP1—malignant glioma	0.00188	0.00471	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00187	0.00469	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—SLC5A5—malignant glioma	0.00186	0.00464	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—NTRK1—malignant glioma	0.00185	0.00463	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.00185	0.00463	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.00185	0.00461	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—EGF—malignant glioma	0.00184	0.00461	CbGpPWpGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TP53—malignant glioma	0.0018	0.00449	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.0018	0.00449	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—ATP1B2—malignant glioma	0.00178	0.00445	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00178	0.00445	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—GSTP1—malignant glioma	0.00177	0.00443	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—SLC6A3—malignant glioma	0.00177	0.00441	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00176	0.00441	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—RTEL1—malignant glioma	0.00167	0.00418	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00164	0.0041	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00163	0.00406	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—NCOR1—malignant glioma	0.00162	0.00405	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00162	0.00404	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—APOD—malignant glioma	0.00159	0.00398	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—PLK1—malignant glioma	0.00156	0.00389	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.00154	0.00385	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00154	0.00385	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—APOD—malignant glioma	0.0015	0.00375	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—GSTP1—malignant glioma	0.00149	0.00374	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—PDGFB—malignant glioma	0.00149	0.00372	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—MYC—malignant glioma	0.00149	0.00372	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00149	0.00372	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00144	0.00361	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.0014	0.00351	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—PDGFB—malignant glioma	0.0014	0.0035	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—PLK1—malignant glioma	0.00139	0.00348	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—HIST1H3B—malignant glioma	0.00138	0.00344	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	0.00134	0.00336	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—ANGPT2—malignant glioma	0.00131	0.00328	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.0013	0.00326	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.0013	0.00325	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00129	0.00323	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.00129	0.00323	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—APOD—malignant glioma	0.00126	0.00316	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00125	0.00313	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00124	0.0031	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.0012	0.003	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.0012	0.00299	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00119	0.00299	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.00119	0.00298	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—PDGFB—malignant glioma	0.00118	0.00295	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—VEGFA—malignant glioma	0.00117	0.00293	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PPARG—malignant glioma	0.00116	0.0029	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—COX8A—malignant glioma	0.00116	0.0029	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00116	0.00289	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.00115	0.00287	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HIST1H3B—malignant glioma	0.00114	0.00284	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—MYB—malignant glioma	0.00113	0.00281	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.00111	0.00279	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—MYC—malignant glioma	0.00108	0.0027	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TOP2A—malignant glioma	0.00107	0.00269	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—H3F3A—malignant glioma	0.00106	0.00266	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.00106	0.00266	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00105	0.00264	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—YWHAE—malignant glioma	0.00103	0.00256	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.00101	0.00251	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.001	0.0025	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000987	0.00247	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ASMT—malignant glioma	0.000986	0.00247	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000984	0.00246	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000973	0.00243	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—COX8A—malignant glioma	0.00096	0.0024	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000952	0.00238	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—BCAN—malignant glioma	0.000927	0.00232	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—MYC—malignant glioma	0.00091	0.00228	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000907	0.00227	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000907	0.00227	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000883	0.00221	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—H3F3A—malignant glioma	0.000878	0.00219	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000868	0.00217	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000861	0.00215	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000858	0.00215	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000858	0.00214	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00083	0.00207	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ASMT—malignant glioma	0.000816	0.00204	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000816	0.00204	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000798	0.00199	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PTEN—malignant glioma	0.000797	0.00199	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000794	0.00198	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BRCA2—malignant glioma	0.000777	0.00194	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN2B—malignant glioma	0.00077	0.00193	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—BCAN—malignant glioma	0.000768	0.00192	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000767	0.00192	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000763	0.00191	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00075	0.00187	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000749	0.00187	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—IDH2—malignant glioma	0.000747	0.00187	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000743	0.00186	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KNG1—malignant glioma	0.000723	0.00181	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000713	0.00178	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IFNA2—malignant glioma	0.000709	0.00177	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000705	0.00176	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP2B6—malignant glioma	0.000703	0.00176	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—MYC—malignant glioma	0.000696	0.00174	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00069	0.00172	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000681	0.0017	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000675	0.00169	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—SOD1—malignant glioma	0.000672	0.00168	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000671	0.00168	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000665	0.00166	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BIRC5—malignant glioma	0.000665	0.00166	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000647	0.00162	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TERT—malignant glioma	0.000644	0.00161	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—IDH1—malignant glioma	0.000643	0.00161	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000642	0.00161	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000637	0.00159	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SPHK1—malignant glioma	0.000622	0.00155	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—IDH2—malignant glioma	0.000619	0.00155	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PTK2—malignant glioma	0.000617	0.00154	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000611	0.00153	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP2C18—malignant glioma	0.000609	0.00152	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000594	0.00149	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000585	0.00146	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000583	0.00146	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP2B6—malignant glioma	0.000582	0.00145	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000566	0.00142	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000566	0.00141	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TP53—malignant glioma	0.000544	0.00136	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—IDH1—malignant glioma	0.000532	0.00133	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.000519	0.0013	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PDGFB—malignant glioma	0.000518	0.0013	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SPHK1—malignant glioma	0.000515	0.00129	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP2C18—malignant glioma	0.000504	0.00126	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTT1—malignant glioma	0.000493	0.00123	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000493	0.00123	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—CAV1—malignant glioma	0.000491	0.00123	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000478	0.0012	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000476	0.00119	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—F2—malignant glioma	0.000467	0.00117	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—FN1—malignant glioma	0.000467	0.00117	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTGS1—malignant glioma	0.000462	0.00115	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CG—malignant glioma	0.000447	0.00112	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—EGF—malignant glioma	0.000442	0.00111	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN2A—malignant glioma	0.00044	0.0011	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PTPN11—malignant glioma	0.00044	0.0011	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000433	0.00108	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—BCHE—malignant glioma	0.000429	0.00107	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MDM2—malignant glioma	0.000427	0.00107	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SLC5A5—malignant glioma	0.000424	0.00106	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000418	0.00105	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—AKT2—malignant glioma	0.000409	0.00102	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTT1—malignant glioma	0.000408	0.00102	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.000405	0.00101	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CD—malignant glioma	0.000393	0.000983	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTGS1—malignant glioma	0.000382	0.000955	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000381	0.000952	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—BCHE—malignant glioma	0.000355	0.000888	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—RAF1—malignant glioma	0.000351	0.000878	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SLC5A5—malignant glioma	0.000351	0.000877	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CB—malignant glioma	0.000343	0.000857	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTP1—malignant glioma	0.000342	0.000854	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MYC—malignant glioma	0.000334	0.000835	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CAT—malignant glioma	0.000332	0.000831	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000332	0.00083	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000331	0.000828	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000329	0.000822	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000323	0.000808	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IL2—malignant glioma	0.000315	0.000787	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NCOR1—malignant glioma	0.000314	0.000785	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000304	0.00076	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MYC—malignant glioma	0.000299	0.000746	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000287	0.000717	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTP1—malignant glioma	0.000283	0.000707	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CAT—malignant glioma	0.000275	0.000688	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—VEGFA—malignant glioma	0.000268	0.000669	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NCOR1—malignant glioma	0.00026	0.000649	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000256	0.000641	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CAV1—malignant glioma	0.000256	0.00064	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—malignant glioma	0.000245	0.000613	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CG—malignant glioma	0.000233	0.000583	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KRAS—malignant glioma	0.000227	0.000569	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PPARG—malignant glioma	0.000225	0.000562	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CAV1—malignant glioma	0.000212	0.000529	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CA—malignant glioma	0.000209	0.000522	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CD—malignant glioma	0.000205	0.000512	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000202	0.000506	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—malignant glioma	0.000202	0.000505	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CG—malignant glioma	0.000193	0.000482	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PPARG—malignant glioma	0.000186	0.000465	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CB—malignant glioma	0.000179	0.000446	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTGS2—malignant glioma	0.000177	0.000442	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—AKT1—malignant glioma	0.000171	0.000427	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CD—malignant glioma	0.00017	0.000424	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTEN—malignant glioma	0.000154	0.000386	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CB—malignant glioma	0.000148	0.00037	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTGS2—malignant glioma	0.000146	0.000366	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTEN—malignant glioma	0.000128	0.000319	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CA—malignant glioma	0.000109	0.000272	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CA—malignant glioma	9.01e-05	0.000225	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKT1—malignant glioma	8.89e-05	0.000222	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKT1—malignant glioma	7.36e-05	0.000184	CbGpPWpGaD
